维普中文期刊产品整合服务
303篇 您的检索式:作者名="HOTTA N"
    题名 作者 年代 出处 被引量
1Circulating concentrations of the adipocyte protein adiponectin are decrdased in with reduced insulin sensitivity during the progression to type2 diabetes in rhesus monkeys显示文摘HOTTA K FUNAHASHI T BODKIN N L 2001Diahetes2001,50,:1
2Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys显示文摘HOTTA K FUNAHASHI T BODKIN N L 2001Diab2001,50,5:1
3Inhibition factor of ammonification in stored urine with fecal contamination 显示文摘Hotta S Funamizu N 2008Water Sci Technol2008,58,6:1
4A comprison of muscle activity and heart rate response during backward and forward walking on an underwater treadmill显示文摘Masumoto K Takasuqi S Hotta N 2007Gait Posture2007,25,2:1
5Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys显示文摘Hotta K Funahashi Bodkin N L 2001Diabetes2001,50,5:1
6Corrosion behavior of fine grained AZ31 B magnesiuma显示文摘Liao JS Hotta M Yamamoto N 2012Corrosion Sci2012,61,:1
7l Clinical efficacy of fidarestat,a novel aldose reductase inhibitor,for diabetic peripheral neuropathy:A 52-week multicenter placebo-controlled doubleblind parallel group study显示文摘Hotta N Toyota T Matsuoka K 0,,:1
8Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats显示文摘Miyazawa S Hotta O Doi N 2004Kidney Int2004,65,6:1
9Depressive mood is independently related to stroke and cardiovascular events in a community显示文摘Yamanaka G Otsuka K Hotta N 0,,1:1
10Clinical efficacy of fidarestat,a novel aldose-reductase inhibitor for diabetic peripheral neuropathy:A 52-week multicenter placebo-controlled double-blind paralled group study显示文摘 Toyota T Matsuoka K 2001Diabetes Care2001,24,10:1
11Clinical efficacy of fidarestat,a novel aldose reductase inhibitor,for diabetic peripheral neuropathy:a 52-week multicenter placebo-controlled double-blind parallel group study显示文摘Hotta N Toyota T Matsuoka K 2001Diabetes Care2001,24,10:1
12Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese patients with non-small cell lung cancer: the okayama lung cancer study group experience 显示文摘Hotta K Kiura K Takigawa N 2010J Thorac Oncol2010,5,2:1
13Circulation concentrations of the adipocyte protein, adiponectin, are decreased in parallel with reduced in sulin sensitivity during the progression to type 2 dia betes in rhesus monkeys显示文摘HOTTA K FUNAHASHI T BODKIN N L 2001Diabetes2001,50,:1
14Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy显示文摘 Hotta O Yusa N 2007Ren Fail2007,29,1:1
15New approaches for treatment in diabetes : aldose reductase inhibitors 显示文摘Hotta N 1995Biomed Phamacother1995,49,5:1
16Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys 显示文摘Hotta K Funahashi T Bodkin N L 2001Diabetes2001,50,5:1
17Association between obesity and polymorphisms in SEC16B,TMEM18,GNPDA2,BDNF,FAIM2 and MC4R in a Japanese population显示文摘Hotta K Nakamura M Nakamura T Matsuo T Nakata Y Kamohara S Miyatake N Kotani K Komatsu R Itoh N Mineo I Wada J Masuzaki H Yoneda M Nakajima A Funahashi T Miyazaki S Tokunaga K Kawamoto M Ueno T Hamaguchi K Tanaka K Yamada K Hanafusa T Oikawa S Yoshimatsu 0,,12:1
18Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensi - tivity during the progression to type 2 diabetes in rhesus monkeys显示文摘Hotta K Funabashi T Bodkon N L 2001Diabetes2001,50,5:1
19Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy显示文摘Hotta N Toyota T Matsuoka K 2001Diabetes care2001,24,10:1
20Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefltinib treatment in Japanese patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experience 显示文摘HOTTA K KIURA K TAK1GAWA N 2010JThoracOacol2010,5,2:1
返回顶部 每页显示:
共16页 首页 上一页 第1页 下一页 末页 /16 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费